Capricor Therapeutics, Inc. (CAPR)
8.37
+0.07
(+0.84%)
USD |
NASDAQ |
Sep 11, 16:00
8.75
+0.38
(+4.54%)
After-Hours: 07:15
Capricor Therapeutics Price to Book Value : 1.975 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.975 |
| September 10, 2026 | 1.959 |
| September 09, 2026 | 2.039 |
| September 08, 2026 | 2.138 |
| September 04, 2026 | 2.218 |
| September 03, 2026 | 2.190 |
| September 02, 2026 | 2.334 |
| September 01, 2026 | 2.362 |
| August 31, 2026 | 2.339 |
| August 28, 2026 | 2.263 |
| August 27, 2026 | 2.374 |
| August 26, 2026 | 2.209 |
| August 25, 2026 | 1.956 |
| August 24, 2026 | 1.605 |
| August 21, 2026 | 1.484 |
| August 20, 2026 | 1.613 |
| August 19, 2026 | 1.883 |
| August 18, 2026 | 1.671 |
| August 17, 2026 | 1.758 |
| August 14, 2026 | 1.569 |
| August 13, 2026 | 0.9936 |
| August 12, 2026 | 0.9889 |
| August 11, 2026 | 0.9275 |
| August 10, 2026 | 0.9086 |
| August 07, 2026 | 0.9653 |
| Date | Value |
|---|---|
| August 06, 2026 | 0.9865 |
| August 05, 2026 | 0.9275 |
| August 04, 2026 | 0.9841 |
| August 03, 2026 | 0.9912 |
| July 31, 2026 | 0.9086 |
| July 30, 2026 | 0.9889 |
| July 29, 2026 | 1.551 |
| July 28, 2026 | 1.551 |
| July 27, 2026 | 1.651 |
| July 24, 2026 | 4.649 |
| July 23, 2026 | 4.68 |
| July 22, 2026 | 4.463 |
| July 21, 2026 | 4.670 |
| July 20, 2026 | 4.602 |
| July 17, 2026 | 4.588 |
| July 16, 2026 | 4.512 |
| July 15, 2026 | 4.803 |
| July 14, 2026 | 4.881 |
| July 13, 2026 | 4.864 |
| July 10, 2026 | 5.076 |
| July 09, 2026 | 5.310 |
| July 08, 2026 | 5.251 |
| July 07, 2026 | 5.244 |
| July 06, 2026 | 5.294 |
| July 02, 2026 | 5.478 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| REGENXBIO, Inc. | 6.438 |
| Cytokinetics, Inc. | -- |
| Emergent BioSolutions, Inc. | 0.9361 |
| Rigel Pharmaceuticals, Inc. | 2.071 |
| United Therapeutics Corp. | 3.315 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0694 |
| Price | 8.37 |
| Earnings Yield | -29.26% |
| Market Cap | 486.37M |
| PEGY Ratio | -0.0694 |